1789.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 05:31):

Stats
Šios dienos apimtis	890 000
Vidutinė apimtis	2.77M
Rinkos kapitalizacija	6.89B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0600 ( 2023-06-21 )
Next Dividend	HKD0 ( N/A )
P/E	36.35
ATR14	HKD0.0250 (0.40%)

Tūris Koreliacija

Ilgas: 0.13 (neutral)

Trumpas: 0.54 (weak)

Signal:(54.295) Neutral

AK Medical Holdings Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

AK Medical Holdings Ltd Koreliacija - Valiuta/Žaliavos

-0.10
( neutral )

0.01
( neutral )

0.00
( neutral )

0.31
( neutral )

-0.82
( strong negative )

-0.19
( neutral )

AK Medical Holdings Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	HKD1.09B
Bruto pelnas:	HKD674.49M (61.66 %)
EPS:	HKD0.160

FY	2023
Pajamos:	HKD1.09B
Bruto pelnas:	HKD674.49M (61.66 %)
EPS:	HKD0.160

FY	2022
Pajamos:	HKD1.05B
Bruto pelnas:	HKD636.44M (60.49 %)
EPS:	HKD0.180

FY	2021
Pajamos:	HKD761.44M
Bruto pelnas:	HKD499.19M (65.56 %)
EPS:	HKD0.0840

Financial Reports:

No articles found.

AK Medical Holdings Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0600 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

AK Medical Holdings Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.34 - Decrease likely (53.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0350	2018-06-21
Last Dividend	HKD0.0600	2023-06-21
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	HKD0.270	--
Avg. Dividend % Per Year	0.00%	--
Score	2.49	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.34
Div. Directional Score	6.44	--

Next Divdend (Est)
(2025-03-31)

HKD0.0750 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.49

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2778.HK	Ex Dividend Junior	2023-09-15	Semi-Annually	0.00%
1449.HK	Ex Dividend Junior	2023-05-24	Insufficient data to determine frequency	0.00%
0533.HK	Ex Dividend Knight	2023-09-05	Semi-Annually	0.00%
6896.HK	Ex Dividend Junior	2023-06-16	Annually	0.00%
1982.HK	Ex Dividend Junior	2023-07-06	Annually	0.00%
1051.HK	Ex Dividend Junior	2023-06-26	Sporadic	0.00%
0124.HK	No Dividend Player	2023-10-06	Sporadic	0.00%
3396.HK	No Dividend Player	2023-07-03	Annually	0.00%
1599.HK	Ex Dividend Junior	2023-05-31	Annually	0.00%
0639.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.168	1.500	6.65	9.97	[0 - 0.5]
returnOnAssetsTTM	0.0677	1.200	7.74	9.29	[0 - 0.3]
returnOnEquityTTM	0.0859	1.500	-0.157	-0.235	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.96	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.70	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.665	1.500	7.42	10.00	[0.2 - 2]
debtRatioTTM	0.0233	-1.500	9.61	-10.00	[0 - 0.6]
interestCoverageTTM	212.05	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0129	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.0885	2.00	-0.0443	-0.0885	[0 - 20]
debtEquityRatioTTM	0.0293	-1.500	9.88	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.604	1.000	3.27	3.27	[0.2 - 0.8]
operatingProfitMarginTTM	0.171	1.000	8.59	8.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.205	1.000	9.97	9.97	[0.2 - 2]
assetTurnoverTTM	0.404	0.800	-0.637	-0.510	[0.5 - 2]
Total Score				10.53

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.48	1.000	7.02	0	[1 - 100]
returnOnEquityTTM	0.0859	2.50	-0.101	-0.235	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0885	2.00	-0.0295	-0.0885	[0 - 30]
dividendYielPercentageTTM	1.079	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0129	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.394	1.500	-0.706	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0118	1.000	-2.20	0	[0.1 - 0.5]
Total Score				2.34

AK Medical Holdings Ltd

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.